Summary: The aim of this study was to examine whether organic cation/carnitine transporter 2 (OCTN2/ SLC22A5) plays a role in the human blood-brain barrier (BBB) by evaluating its functional activity in human brain endothelial cells (hCMEC/D3), which are considered to be a model of the BBB. The uptake of [
Introduction
The blood-brain barrier (BBB) is formed by brain capillary endothelial cells linked with tight junctions. 1) In the rodent brain, it is well established that the homeostatic balance of nutrients and waste products is maintained by appropriate regulation of the functions of numerous transporter proteins expressed at the BBB. 2) However, transporter expression and function at the human BBB are less well understood.
Recently, human immortalized brain capillary endothelial cells (hCMEC/D3) have been developed as an in vitro human BBB model. 3) This cell line has been extensively validated by means of pharmacological, toxicological, immunological and infection studies in numerous laboratories worldwide, and it is established that hCMEC/D3 cells retain many of the morphological and functional characteristics of human brain capillary endothelial cells. 4) We have reported that the proton/organic cation (H + /OC) antiporter is functionally expressed in hCMEC/D3 cells, 5) although the molecular entity of H + /OC remains unknown. This antiporter mediates blood-to-brain transport of CNS-acting cationic drugs such as pramipexole, oxycodone and diphenhydramine, in addition to pyrilamine. [5] [6] [7] [8] Further, we have shown that the in vivo human BBB permeability of cationic drugs can be roughly predicted from the in vitro uptake clearance estimated in hCMEC/D3 cells. 5) In addition, it has been found that organic cation/carnitine transporter 2 (OCTN2/SLC22A5) is abundantly expressed in hCMEC/ D3 cells at the mRNA level. 5) OCTN2 is the major transporter of L-carnitine, 9, 10) which mediates translocation of acetyl moiety and contributes to the synthesis of acetylcholine and acetyl-Lcarnitine in the brain. 11, 12) Because of the physiological roles of these compounds in the cholinergic neurons, the effects of Lcarnitine and its metabolites on the central nervous system (CNS) have attracted increasing attention. 13) Indeed, it has also been shown that L-carnitine and acetyl-L-carnitine are relevant to the pathology of Alzheimer's disease. Although OCTN2 in the rodent BBB has been reported to transport L-carnitine and acetyl-Lcarnitine, 14) our knowledge of OCTN2 function at the human BBB remains incomplete. Investigation of this issue would improve our understanding of human cerebral physiology and pathology, and also contribute to the development of new CNS drugs targeting OCTN2 at the BBB.
The aim of this study, therefore, was to examine the transport function of OCTN2 in hCMEC/D3 cells as a model of the human BBB. The RNA interference (RNAi) method is a suitable approach for this purpose. Small interfering RNA (siRNA)-mediated depletion of a tight junction-related protein and an organic cation transporter expressed in human and rat brain capillary endothelial cell lines has already been reported. 15, 16) Thus, we applied the RNAi method to investigate OCTN2 function in hCMEC/D3 cells. Cell culture: The hCMEC/D3 cell line had been immortalized by lentiviral transduction of the catalytic subunit of human telomerase and SV40-T antigen into brain endothelial microvascular cells isolated from brain tissue following surgical excision of an area from the temporal lobe of an adult female with epilepsy. 3) These cells were cultured in EBM-2 medium (Takara Bio, Shiga, Japan) supplemented with 2.5% fetal bovine serum, 0.025% vascular endothelial growth factor, 0.025% insulin-like growth factor-1, 0.025% epidermal growth factor, 5 µg/mL basic fibroblast growth factor, 0.01% hydrocortisone, 1% penicillin-streptomycin and 10 mM HEPES on rat collagen type I coated dishes. They were maintained in 95% air and 5% CO 2 at 37°C.
Materials and Methods

Chemicals
In vitro uptake studies: The hCMEC/D3 cells used for the experiments were between passage 25 and 35. In vitro uptake studies were performed as previously reported. 5) hCMEC/D3 cells were seeded on type I collagen-coated 24-well plates (BIOCOAT, Becton Dickinson, Bedford, MA) at a density of 20,000 cells/cm 2 . The cells reached confluence at 3-4 days after seeding, and then were washed twice with 1 mL of incubation buffer (122 mM NaCl, 3 mM KCl, 25 mM NaHCO 3 , 1.2 mM MgSO 4 , 1.4 mM CaCl 2 , 10 mM D-glucose, and 10 mM HEPES, pH 7.4) and preincubated with incubation buffer for 20 min at 37°C. After preincubation, the buffer (0.25 mL) containing [ 3 H]L-carnitine (30 nM) was added to initiate uptake. The cells were incubated at 37°C for a designated time (0.5, 1, 3, 10 and 20 min), and then washed three times with 1 mL of ice-cold incubation buffer to terminate the uptake. For the determination of [ 3 H]L-carnitine radioactivity, the cells were lysed with 1 M NaOH for 60 min. The radioactivity was measured using a liquid scintillation counter after addition of the scintillation cocktail Hionic-Fluor (PerkinElmer Life and Analytical Sciences). Cellular protein content was determined with a BCA protein assay kit (Pierce Chemical Co., Rockford, IL).
Uptake was expressed as the cell-to-medium ratio (µL/mg protein) obtained by dividing the uptake amount by the concentration of [ 3 H]L-carnitine in the incubation buffer. The initial uptake of [ 3 H]L-carnitine (for 10 min) was also measured under an Na + -free condition (Na + was replaced with N-methylglucamine + ) and in the presence of unlabelled L-carnitine. In order to estimate the kinetic parameters, the [ 3 H]L-carnitine uptake (0.03, 1, 3, 10, 30 and 100 µM, for 10 min) was measured as the initial uptake velocity (pmol/mg protein/10 min) and it was fitted to the following equation by means of nonlinear least-squares regression analysis with Prism software (Graphpad, San Diego, CA):
where v, s, V max , K m and K ns represent the initial uptake velocity (pmol/mg protein/min), [ 3 H]L-carnitine concentration (µM), maximum uptake velocity (pmol/mg protein/min), Michaelis constant (µM), and the first-order constant for the non-saturable component (µL/mg protein/min), respectively. The K ns value was estimated on the assumption that most of the uptake at the concentration of 10 mM is the non-saturable component. 5, 7) The K ns value was 0.042 µL/mg protein/min.
Real-time PCR analysis: The mRNA levels of organic cation transporters, organic cation transporter (OCT) 1 (SLC22A1), OCT2 (SLC22A2), OCT3 (SLC22A3), OCTN1 (SLC22A4), OCTN2 (SLC22A5), CT2 (SLC22A16) and ATB 0+ (SLC6A14), in hCMEC/D3 cells were measured by quantitative real-time PCR analysis. 5) Total RNA was isolated from hCMEC/D3 cells using an RNeasy mini kit (QIAGEN, Valencia, CA). Single-strand cDNA was prepared from 1.0 µg of total RNA with reverse transcriptase (Superscript III, Life Technologies) using random primers. Quantitative real-time PCR analysis was performed using a model 7500 sequence detection system (Life Technologies) with 2© SYBR Green PCR Master Mix (Life Technologies) according to the manufacturer's protocols. The primers used for OCT1-3, OCTN1-2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were as previously reported. 5) Other primers were 5A-GGA GTC ACC CCT CAT CAT GTC T-3A and 5A-GAT TAT GGA AAA CAA CCT GAC TCA CA-3A for CT2, 5A-TCT GTG TGA CTC AGG CTG GAA T-3A and 5A-ATG TAG CCA CTG TGG TCC TCA A-3A for ATB 0+ , 5A-GCC CCA TCC AGC ACA GAA-3A and 5A-CAC ATC ACA GCT CCC CAC CA-3A for TATA box binding protein (TBP). The thermal protocol was set to 2 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 s at 95°C and 1 min at 60°C. The relative expression levels of these mRNAs were calculated using the comparative Ct method for relative quantification based on the mRNA level of the housekeeping gene encoding TBP, according to the manufacturer's protocols. GAPDH mRNA was also measured for optimization of transfection conditions using GAPDH siRNA, as described below. The control, lacking the RT enzyme, was assayed in parallel to monitor genomic contamination. To confirm specificity of amplification, the PCR products were subjected to melting curve analysis.
Optimization of conditions for siRNA transfection into hCMEC/D3 cells: hCMEC/D3 cells seeded on Glass Bottom Culture Dishes (MatTek, Ashland, MA) were transfected with fluorescence-labeled siRNA (QIAGEN) at the concentration of 33 or 10 nM by using Lipofectamine 2000 or Lipofectamine RNAiMAX (1 µL/cm 2 ), respectively. At 24 h after transfection, they were washed with PBS three times and viewed with a confocal laser microscope, Fluoview FV10i (Olympus, Tokyo, Japan). Next, gene silencing was evaluated by using the siRNA for the target sequence of GAPDH cDNA (TGGTTTACATGTTCC-AATA) (Invitrogen). hCMEC/D3 cells were seeded on collagencoated 6-or 24-well plates at a density of 20,000 cells/cm 2 . At 24 h after seeding, the cells were treated with 33 nM GAPDH siRNA by using Lipofectamine 2000 (1 µL/cm 2 ) or 1.25-10 nM GAPDH siRNA by using Lipofectamine RNAiMAX (0.5-1 µL/cm 2 ). At 48 h after transfection, GAPDH mRNA was measured by quantitative real-time PCR analysis as described above.
RNA interference analysis: For gene silencing of OCTN2, we used a set of two siRNAs (Invitrogen) for the target sequences of OCTN2 (CCATATCAGTGGGCTATTT and GGATGTTAAAA-GATGGTCA). hCMEC/D3 cells were seeded on collagen-coated 6-or 24-well plates at a density of 20,000 cells/cm 2 . At 24h after seeding, siRNAs for OCTN2 (each 0.1-25 nM) were transfected into hCMEC/D3 cells with Lipofectamine RNAiMAX (0. 3 H]L-carnitine increased with time, and the values of the cell-tomedium ratio were 2.6 and 4.1 µL/mg protein at 10 and 20 min, respectively (Fig. 1A) . The initial uptake was assessed at 10 min in subsequent studies. The cell-to-medium ratio of initial [ 3 H]Lcarnitine uptake was significantly inhibited by the replacement of extracellular Na + with N-methylglucamine + (Fig. 1B) (Fig. 1C) . The initial uptake velocity of [
3 H]L-carnitine was concentration-dependent, with a K m value of 15.7 µM and a V max value of 2.25 pmol/mg protein/min (Fig. 1D) .
mRNA expression of organic cation and carnitine transporters in hCMEC/D3 cells: mRNA expression levels of organic cation and carnitine transporters in hCMEC/D3 cells were determined. The level of OCTN2 (SLC22A5) mRNA was the highest, followed by OCTN1 (SLC22A4) and ATB 0+ (SLC6A14) (Fig. 2) . Slight mRNA expression of OCT1 (SLC22A1), OCT3 (SLC22A3) and CT2 (SLC22A16) was detected, but OCT2 (SLC22A2) mRNA was not detected.
Optimization of conditions of siRNA transfection into hCMEC/D3 cells: Fluorescence-labeled siRNA was transfected into hCMEC/D3 cells by using Lipofectamine 2000 or Lipofectamine RNAiMAX. Fluorescent siRNA was observed in most of the washed cells at 24 h after transfection using both Lipofectamine 2000 (Fig. 3A) and Lipofectamine RNAiMAX (Fig. 3B) . The transfection of GAPDH siRNA (33 or 10 nM, respectively) using Lipofectamine 2000 or Lipofectamine RNAi-MAX resulted in a dramatic decrease of GAPDH mRNA in hCMEC/D3 cells (Fig. 4A) . Neither of the transfection reagents affected the level of GAPDH mRNA in the absence of GAPDH siRNA. GAPDH mRNA expression was reduced by GAPDH siRNA (10 nM) transfection with Lipofectamine RNAiMAX at the amount of 0.5, 0.75 or 1 µL/cm 2 ( Fig. 4B) and by 1.25-10 nM GAPDH siRNA transfected with Lipofectamine RNAiMAX (0.5 µL/cm 2 ) (Fig. 4C) . These results indicate that GAPDH mRNA expression was effectively suppressed by the transfection of GAPDH siRNA (1.25-10 nM) with Lipofectamine RNAiMAX (0.5 µL/cm 2 ). Effect of OCTN2 siRNA transfection: Transfection of OCTN2 siRNA with Lipofectamine RNAiMAX (0.5 µL/cm 2 ) decreased OCTN2 mRNA expression in a concentration-dependent manner and similar effects were observed at the concentrations of 1-25 nM (Fig. 5) . OCTN2 siRNAs were transfected at the concentration of 5 nM in subsequent studies. At 24-72 h after the transfection, OCTN2 mRNA expression was decreased by 89-93% . Each column represents the mean « S.E. of three determinations. Asterisks show a significant difference, ***p < 0.001 versus control. (Fig. 6) . OCTN1 mRNA was not significantly decreased by the transfection of OCTN2 siRNA (data not shown). The cell-tomedium ratio of initial [ 3 H]L-carnitine uptake was decreased by 81 and 83% at 48 and 72 h after OCTN2 siRNA transfection, respectively (Fig. 7) . The initial uptake after OCTN2 siRNA transfection was similar to the uptake in the presence of 10 mM unlabeled L-carnitine.
Discussion
In the current study, we examined the functional expression of OCTN2 in the hCMEC/D3 cell line as a human BBB model, using [ , as well as OCTN2. [17] [18] [19] Therefore, we applied the RNAi method, which should make it possible to evaluate the function of only the target transporter. The hCMEC/D3 cells retain relatively high levels of expression of OCTN2 mRNA and sodium-and concentration-dependent transport of [ Protein expression of OCTN2 was detected in bovine brain endothelial cells by immunohistochemical analysis. 21) Quantitative targeted proteomics showed protein expression of 10 SLC transporters, including excitatory amino acid transporter 1 (EAAT1), glucose transporter 1 (GLUT1), and monocarboxylate transporter 1 (MCT1), in isolated human and mice brain microvessels, while no protein expression was observed for 56 SLC transporters, including organic cation transporters (OCTs) and OCTNs. 22) But, although the protein expression level of OCTN2 in the BBB was lower than the limit of quantification by quantitative targeted proteomics, OCTN2-mediated transport function was observed in the present study. The L-carnitine transport by OCTN2 is driven by the Na + concentration gradient from the extracellular fluid (145 mM) to the intracellular fluid (5-15 mM). Despite the low protein expression of OCTN2 in the BBB, the large concentration gradient of Na + between the intracellular and extracellular fluid appears to effectively drive OCTN2-mediated transport of L-carnitine. Thus, it is important to consider the driving force in evaluating the transport function of individual transporters at the BBB, in addition to the protein expression level. 
